The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress

Stephanie B. Dixon; Eric J. Chow; Lars Hjorth; Melissa M. Hudson; Leontien C.M. Kremer; Lindsay M. Morton; Paul C. Nathan; Kirsten K. Ness; Kevin C. Oeffinger; Gregory T. Armstrong

doi:10.1016/j.pcl.2020.07.013

The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress

Stephanie B. Dixon, Eric J. Chow, Lars Hjorth, Melissa M. Hudson, Leontien C.M. Kremer, Lindsay M. Morton, Paul C. Nathan, Kirsten K. Ness, Kevin C. Oeffinger, Gregory T. Armstrong

Group Kremer

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel recenseren › peer review

22 Citaten (Scopus)

Samenvatting

As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.

Originele taal-2	Engels
Pagina's (van-tot)	1237-1251
Aantal pagina's	15
Tijdschrift	Pediatric Clinics of North America
Volume	67
Nummer van het tijdschrift	6
DOI's	https://doi.org/10.1016/j.pcl.2020.07.013
Status	Gepubliceerd - dec. 2020

Toegang tot document

10.1016/j.pcl.2020.07.013

Citeer dit

@article{3447625b5dc44922a48cad86e411b1a2,

title = "The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress",

abstract = "As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.",

keywords = "Adolescent, Cancer, Child, Delivery of health care, Neoplasms, Survivor, Treatment outcome",

author = "Dixon, {Stephanie B.} and Chow, {Eric J.} and Lars Hjorth and Hudson, {Melissa M.} and Kremer, {Leontien C.M.} and Morton, {Lindsay M.} and Nathan, {Paul C.} and Ness, {Kirsten K.} and Oeffinger, {Kevin C.} and Armstrong, {Gregory T.}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = dec,

doi = "10.1016/j.pcl.2020.07.013",

language = "English",

volume = "67",

pages = "1237--1251",

journal = "Pediatric Clinics of North America",

issn = "0031-3955",

publisher = "W.B. Saunders",

number = "6",

}

TY - JOUR

T1 - The Future of Childhood Cancer Survivorship

T2 - Challenges and Opportunities for Continued Progress

AU - Dixon, Stephanie B.

AU - Chow, Eric J.

AU - Hjorth, Lars

AU - Hudson, Melissa M.

AU - Kremer, Leontien C.M.

AU - Morton, Lindsay M.

AU - Nathan, Paul C.

AU - Ness, Kirsten K.

AU - Oeffinger, Kevin C.

AU - Armstrong, Gregory T.

PY - 2020/12

Y1 - 2020/12

N2 - As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.

AB - As treatment evolves and the population who survive childhood cancer ages and increases in number, researchers must use novel approaches to prevent, identify and mitigate adverse effects of treatment. Future priorities include collaborative efforts to pool large cohort data to improve detection of late effects, identify late effects of novel therapies, and determine the contribution of genetic factors along with physiologic and accelerated aging among survivors. This knowledge should translate to individual risk prediction and prevention strategies. Finally, we must utilize health services research and implementation science to improve adoption of survivorship care recommendations outside of specialized pediatric oncology centers.

KW - Adolescent

KW - Cancer

KW - Child

KW - Delivery of health care

KW - Neoplasms

KW - Survivor

KW - Treatment outcome

UR - http://www.scopus.com/inward/record.url?scp=85094202228&partnerID=8YFLogxK

U2 - 10.1016/j.pcl.2020.07.013

DO - 10.1016/j.pcl.2020.07.013

M3 - Review article

C2 - 33131544

AN - SCOPUS:85094202228

SN - 0031-3955

VL - 67

SP - 1237

EP - 1251

JO - Pediatric Clinics of North America

JF - Pediatric Clinics of North America

IS - 6

ER -

The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress

Samenvatting

Toegang tot document

Vingerafdruk

Citeer dit